Daratumumab maintenance in patients with myeloma
| dc.authorscopusid | Meral Beksac / 56924887200 | |
| dc.authorwosid | Meral Beksac / D-6411-2013 | |
| dc.contributor.author | Beksac, Meral | |
| dc.date.accessioned | 2025-04-18T10:36:25Z | |
| dc.date.available | 2025-04-18T10:36:25Z | |
| dc.date.issued | 2024 | |
| dc.department | İstinye Üniversitesi, Tıp Fakültesi, İSÜ Hastaneleri | |
| dc.description.abstract | Daratumumab maintenance in patients with myeloma | |
| dc.identifier.citation | Beksac, M. (2024). Daratumumab maintenance in patients with myeloma. The Lancet Oncology, 25(8), 947-948. | |
| dc.identifier.doi | 10.1016/S1470-2045(24)00341-3 | |
| dc.identifier.endpage | 948 | |
| dc.identifier.issn | 1470-2045 | |
| dc.identifier.issn | 1474-5488 | |
| dc.identifier.issue | 8 | |
| dc.identifier.pmid | 38889736 | |
| dc.identifier.scopus | 2-s2.0-85197069468 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 947 | |
| dc.identifier.uri | http://dx.doi.org/10.1016/S1470-2045(24)00341-3 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12713/7141 | |
| dc.identifier.volume | 25 | |
| dc.identifier.wos | WOS:001282720800001 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.institutionauthor | Beksac, Meral | |
| dc.institutionauthorid | Meral Beksac / 0000-0003-1797-8657 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier | |
| dc.relation.ispartof | Lancet oncology | |
| dc.relation.publicationcategory | DiÄŸer | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.title | Daratumumab maintenance in patients with myeloma | |
| dc.type | Other |
